Bristol-Myers Squibb Company
NYSE: BMY
$49.41
+$0.39 (+0.8%)
Closing Price on September 20, 2024
BMY Articles
One good idea now may be to take some profit on winners and look for some contrarian ideas that could have solid upside and a degree of safety.
Published:
Last Updated:
The April 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
LendingClub, Coca-Cola, Acadia Pharmaceuticals, and Bristol-Myers Squibb all posted new 52-week lows Wednesday.
Published:
Last Updated:
The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
24/7 Wall St. has put together a preview of AbbVie, Eli Lilly and some of the other top pharma and biotech companies reporting their latest quarterly results in the coming week.
Published:
Last Updated:
Mattel, NXP Semiconductor, Bristol-Myers, and Kraft Heinz all posted new 52-week lows Friday.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Tuesday include Bristol-Myers Squibb, Chesapeake Energy, Coca-Cola, Dropbox, GrubHub, Merck, National Oilwell Varco, Netflix and...
Published:
Last Updated:
Lung cancer may have just met a new standard of care. On top of that, it would be considered a new standard as a first line of care in lung cancer and longer overall survival rates.
Published:
Last Updated:
Monday was a positive day for the broad U.S. markets with all three major indices posting a solid gain to start the week. Although the averages performed well in the session, Crude oil pulled back...
Published:
Last Updated:
The March 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
The March 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Wednesday include Applied Materials, Celgene, Children's Place, Kinder Morgan, Match, Myriad Genetics, Nordstrom and Oracle.
Published:
Last Updated:
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
The February 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks increased.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Thursday include AMAG Pharmaceuticals, Baidu, Cisco, General Electric, Honeywell, 3M, Salesforce.com, SunPower and United...
Published:
Last Updated: